Estos frmacos incluyen semaglutida (Ozempic, Wegovy), dulaglutida (Trulicity), liraglutida (Victoza, Saxenda) y tirzepatida (Mounjaro, Zepbound), aunque tirzepatida es tcnicamente un agonista dual que acta sobre los receptores GIP y GLP-1
GLP-1 medicines may increase hypoglycemia risk when combined with insulin or sulfonylureas and may delay stomach emptying, affecting absorption of some oral medicines
A seventeenth-century Mycobacterium tuberculosis genome supports a Neolithic emergence of the Mycobacterium tuberculosis complex
GHSs : After a 16-week cycle, a user might drop the dose to the beginner range and only inject 3-4 times per week, or cycle off completely for 4-8 weeks
The point is not that Replenza is wrong for any particular GLP-1 medication